Antibodies against Mucin-Based Glycopeptides AffectTrypanosoma cruziCell Invasion and Tumor Cell Viability

α-Selective glycosylation affords mucin-related GalNAc amino acids and diketopiperazines active on Trypanosoma cruzi

(2013) Maristela B. Martins-Teixeira et al.   BIOORGANIC & MEDICINAL CHEMISTRY

The development of synthetic antitumour vaccines from mucin glycopeptide antigens

(2013) Nikola Gaidzik et al.   CHEMICAL SOCIETY REVIEWS

Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi

(2013) Lucia Mendonça-Previato et al.   GLYCOCONJUGATE JOURNAL

A Vision for Vaccines Built from Fully Synthetic Tumor-Associated Antigens: From the Laboratory to the Clinic

(2013) Rebecca M. Wilson et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease

(2013) Roger A. Ashmus et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial

(2013) Nuhad K. Ibrahim et al.   Journal of Cancer

Fully Synthetic Self-Adjuvanting Thioether-Conjugated GlycopeptideLipopeptide Antitumor Vaccines for the Induction of Complement-Dependent Cytotoxicity against Tumor Cells

(2012) Hui Cai et al.   CHEMISTRY-A EUROPEAN JOURNAL

Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects

(2012) Eric Dumonteil et al.   Expert Review of Vaccines

The Tn Antigen-Structural Simplicity and Biological Complexity

(2011) Tongzhong Ju et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Advances and challenges towards a vaccine against Chagas disease

(2011) Israel Quijano-Hernandez et al.   Human vaccines & immunotherapeutics

Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening

(2011) Grasiella Andriani et al.   PLoS Neglected Tropical Diseases

Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue

(2010) Anja Hoffmann-Röder et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

The Kinetoplastid Chemotherapy Revisited: Current Drugs, Recent Advances and Future Perspectives

(2010) E. Castillo et al.   CURRENT MEDICINAL CHEMISTRY

Chagas disease

(2010) Anis Rassi et al.   LANCET

Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines

(2009) Q. Li et al.   MOLECULAR CANCER THERAPEUTICS

Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptide Antigens and a T-Cell Epitope for the Induction of a Highly Specific Humoral Immune Response

(2008) Ulrika Westerlind et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Glycoconjugates in Cancer Therapy

(2008) Laura Cipolla et al.   Anti-Cancer Agents in Medicinal Chemistry

The study of immunological component in antitumor effect of Trypanosoma cruzi

(2008) A. V. Zenina et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Iodine-mediated glycosylation en route to mucin-related glyco-aminoacids and glycopeptides

(2008) Tiina S. Kärkkäinen et al.   CARBOHYDRATE RESEARCH